MedTrace Logo

Bodytrak® Feasibility Study

NCT03139955 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2019-04-19

No results posted yet for this study

Summary

Bodytrak® is a wireless earpiece which can monitor the user's vital signs such as tympanic (ear) temperature and heart rate. The earpiece is non-invasive and should fit comfortably within the right ear, similar to an earphone with an over-the-ear hook. Bodytrak is currently in a prototype stage.

The purpose of this study is to assess the feasibility of conducting a trial investigating the integration of Bodytrak in an NHS (National Health Service) environment at Chelsea and Westminster Hospital; to collect patient vital sign data for the development of Bodytrak algorithms to detect the transition point of recovery/deterioration of health, as well as the level of consciousness; and to obtain nurse and patient feedback regarding their user experience of Bodytrak.

Conditions

  • Monitoring, Physiologic
  • Vital Signs
  • Sepsis
  • Altered Level of Consciousness

Interventions

DEVICE

Bodytrak

Bodytrak is a wireless earpiece which can monitor the user's vital signs such as tympanic (ear) temperature and heart rate. The earpiece is non-invasive and should fit comfortably within the right ear, similar to an earphone with an over-the-ear hook. Bodytrak is currently in a prototype stage. For further information please visit http://www.bodytrak.co

Sponsors & Collaborators

  • Chelsea and Westminster NHS Foundation Trust

    collaborator OTHER

  • Innovate UK

    collaborator OTHER_GOV

  • Inova Design Solutions Ltd

    lead INDUSTRY

Principal Investigators

  • Marcela Vizcaychipi, Dr · Chelsea and Westminster NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2019-11-01
Completion
2019-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139955 on ClinicalTrials.gov